January 2026 FDA Recall Bisoprolol Fumarate And Hydrochlorothiazide by Unichem Pharmaceuticals Usa Inc.
D-0301-2026 - cGMP Deviations

This Class II drug recall was voluntarily initiated by Unichem Pharmaceuticals Usa Inc. on January 21, 2026 for the product Bisoprolol Fumarate And Hydrochlorothiazide. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0301-2026

Reason for Recall
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Initiated
01-21-2026
Reported
02-11-2026
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Unichem Pharmaceuticals USA Inc.
US Nationwide and PR.
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Batch or Lot Expiration Information

Lot# GBHL24005A, Exp Date: 09/2026